<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotics for acute laryngitis in adults - Reveiz, L - 2015 | Cochrane Library</title> <meta content="Antibiotics for acute laryngitis in adults - Reveiz, L - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004783.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotics for acute laryngitis in adults - Reveiz, L - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004783.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004783.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotics for acute laryngitis in adults" name="citation_title"/> <meta content="Ludovic Reveiz" name="citation_author"/> <meta content="mmreveiz@hotmail.com" name="citation_author_email"/> <meta content="Andrés Felipe Cardona" name="citation_author"/> <meta content="Institute of Oncology, Fundación Santa Fe de Bogotá" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD004783.pub5" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/05/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004783.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004783.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004783.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Anti‐Bacterial Agents [*therapeutic use]; Clarithromycin [therapeutic use]; Depsipeptides; Erythromycin [therapeutic use]; Fusarium; Laryngitis [*drug therapy]; Penicillin V [therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004783.pub5&amp;doi=10.1002/14651858.CD004783.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="jU9oKp1Y";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004783\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004783\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ms","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004783.pub5",title:"Antibiotics for acute laryngitis in adults",firstPublishedDate:"May 23, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004783.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004783.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004783.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004783.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004783.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004783.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004783.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004783.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004783.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004783.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17520 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004783.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-sec-0089"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-sec-0080"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/appendices#CD004783-sec-0094"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/table_n/CD004783StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/table_n/CD004783StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotics for acute laryngitis in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/information#CD004783-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Ludovic Reveiz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004783.pub5/information#CD004783-cr-0003">Andrés Felipe Cardona</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/information/en#CD004783-sec-0111">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 May 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004783.pub5">https://doi.org/10.1002/14651858.CD004783.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004783-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004783-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004783-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004783-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004783-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004783-abs-0001" lang="en"> <section id="CD004783-sec-0001"> <h3 class="title" id="CD004783-sec-0001">Background</h3> <p>This is an update of the original review published in 2005. Acute laryngitis is a common illness worldwide. Diagnosis is often made by case history alone and treatment often targets symptoms. </p> </section> <section id="CD004783-sec-0002"> <h3 class="title" id="CD004783-sec-0002">Objectives</h3> <p>To assess the effectiveness and safety of different antibiotic therapies in adults with acute laryngitis. A secondary objective was to report the rates of adverse events associated with these treatments. </p> </section> <section id="CD004783-sec-0003"> <h3 class="title" id="CD004783-sec-0003">Search methods</h3> <p>We searched CENTRAL (2014, Issue 11), MEDLINE (January 1966 to November week 3, 2014), EMBASE (1974 to December 2014), LILACS (1982 to December 2014) and BIOSIS (1980 to December 2014). </p> </section> <section id="CD004783-sec-0004"> <h3 class="title" id="CD004783-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing any antibiotic therapy with placebo for acute laryngitis. The main outcome was objective voice scores. </p> </section> <section id="CD004783-sec-0005"> <h3 class="title" id="CD004783-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted and synthesised data.</p> </section> <section id="CD004783-sec-0006"> <h3 class="title" id="CD004783-sec-0006">Main results</h3> <p>We included three RCTs (351 participants) that had moderate to high risk of bias. The quality of the evidence was very low for all outcomes. We downgraded the studies because of limitations in study design or execution (risk of bias), imprecision and inconsistency of results. We included a new trial presented only as a conference abstract in this update. </p> <p>In one study of acute laryngitis in adults, 100 participants were randomised to receive penicillin V (800 mg twice daily for five days) or an identical placebo. A recording of each patient reading a standardised text was made at the first visit, during re‐examination after one and two weeks, and at follow‐up after two to six months. No significant differences were found between the groups. The trial also measured symptoms reported by participants and found no significant differences. </p> <p>One study investigated erythromycin for acute laryngitis in 106 adults. The mean objective voice scores measured at the first visit, at re‐examination after one and two weeks, and at follow‐up after two to six months did not significantly differ between the groups. At one week there were significant beneficial differences in the severity of reported vocal symptoms (slight, moderate and severe) as judged by participants (P value = 0.042). However, the rates of participants having improved voice disturbance (subjective symptoms) at one and two weeks were not significantly different among groups. Comparing erythromycin and placebo groups on the rate of persistence of cough at two weeks, the risk ratio (RR) was 0.38 (95% confidence interval (CI) 0.15 to 0.97, P value = 0.04) and the number needed to treat for an additional beneficial outcome (NNTB) was 5.87 (95% CI 3.09 to 65.55). We calculated a RR of 0.64 (95% CI 0.46 to 0.90, P value = 0.034) and a NNTB of 3.76 (95% CI 2.27 to 13.52; P value = 0.01) for the subjective voice scores at one week. </p> <p>A third trial from Russia included 145 patients with acute laryngitis symptoms. Participants were randomised to three treatment groups: Group 1: seven‐day course of fusafungine (six times a day by inhalation); Group 2: seven‐day course of fusafungine (six times a day by inhalation) plus clarithromycin (250 mg twice daily for seven days); Group 3: no treatment. Clinical cure rates were measured at days 5 ± 1, 8 ± 1 and 28 ± 2. The authors reported significant differences in the rates of clinical cure at day 5 ± 1 favouring fusafungine (one trial; 93 participants; RR 1.50, 95% CI 1.02 to 2.20; P value = 0.04) and fusafungine plus clarithromycin (one trial 97 participants; RR 1.47, 95% CI 1.00 to 2.16; P value = 0.05) when compared to no treatment. However, no significant differences were found at days 8 ± 1 and 28 ± 2. Also, no significant differences were found when comparing fusafungine to fusafungine plus clarithromycin at days 5 ± 1, 8 ± 1 and 28 ± 2. </p> </section> <section id="CD004783-sec-0007"> <h3 class="title" id="CD004783-sec-0007">Authors' conclusions</h3> <p>Antibiotics do not appear to be effective in treating acute laryngitis when assessing objective outcomes. They appear to be beneficial for some subjective outcomes. Erythromycin could reduce voice disturbance at one week and cough at two weeks when measured subjectively. Fusafungine could increase the cure rate at day five. The included RCTs had important methodological problems and these modest benefits from antibiotics may not outweigh their cost, adverse effects or negative consequences for antibiotic resistance patterns. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004783-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004783-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004783-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004783-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004783-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004783-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004783-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004783-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD004783-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004783-abs-0003" lang="en"> <h3>Antibiotics to treat adults with acute laryngitis</h3> <p><b>Review question</b> <br/> Cochrane authors reviewed the available evidence from randomised controlled trials on the use of antibiotics for adults with acute laryngitis. </p> <p><b>Background</b> <br/> Acute laryngitis is an inflammation of the larynx. The most common symptoms are hoarseness, fever, sore throat, postnasal discharge and difficulty in swallowing. Antibiotics are frequently prescribed by physicians or self prescribed. Reasons for over‐prescribing antibiotics in upper respiratory tract infections such as acute laryngitis are varied but they often involve physicians' and patients' attitudes and expectations. </p> <p><b>Study characteristics</b> <br/> This review found three studies involving 351 participants evaluating the effectiveness of different antibiotic therapies in adults with acute laryngitis. The evidence is current to December 2014. </p> <p><b>Quality of the evidence</b> <br/> We ranked the quality of the evidence as low to very low, mainly because many studies had methodological limitations, outcome results were based on limited numbers of trials and the trials included participants that could not be pooled. </p> <p><b>Key results</b> <br/> We found that penicillin V and erythromycin appear to have no benefit in treating acute laryngitis. Erythromycin could reduce voice disturbance at one week and cough at two weeks when measured subjectively. Fusafungine could improve the rates of cured patients at day five. Overall, there is no clear benefit for the primary outcome, which is an objective assessment of voice quality, but some improvements are seen in subjective measures (i.e. cough, hoarseness of voice) that could be important to patients. However, we consider that these modest benefits from antibiotics may not outweigh their cost, adverse effects or negative consequences for antibiotic resistance patterns. The implications for practice are that prescribing antibiotics should not be done in the first instance as they will not objectively improve symptoms </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004783-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004783-sec-0089"></div> <h3 class="title" id="CD004783-sec-0090">Implications for practice</h3> <section id="CD004783-sec-0090"> <p>Definitive recommendations cannot be made since evidence is only available from three randomised controlled trials (RCTs). Antibiotics appear to have no benefit in the treatment of acute laryngitis. Erythromycin may reduce voice disturbance at one week and cough at two weeks, measured subjectively, and fusafungine may improve the rates of cured patients at day five (it is unclear how this was measured), however we consider that these outcomes are not relevant in clinical practice. In addition, acute laryngitis requires laryngoscopic findings for a clear diagnosis as hoarseness by itself is not the sole criterion for the assessment of a disease. Overall, there is no clear benefit for the primary outcome, which is objective assessment of voice quality, but some improvements are seen in subjective measures (i.e. cough, hoarseness of voice) that could be important to patients. However, we consider that these modest benefits from antibiotics may not outweigh their cost, adverse effects or negative consequences for antibiotic resistance patterns. The implications for practice are that prescribing antibiotics should not be done in the first instance as they will not objectively improve symptoms. </p> </section> <h3 class="title" id="CD004783-sec-0091">Implications for research</h3> <section id="CD004783-sec-0091"> <p>Definitive recommendations cannot be made based on the evidence provided by these low‐quality trials; antibiotics may reduce voice disturbance and cough, and may increase cure rates. There is a need for high‐quality trials to find out if these effects are real. Future research should address the limitations of previous trial methodologies (e.g. a more accurate diagnosis/case definition using direct laryngoscopy etc.) and adequately evaluate objective clinical outcomes. Study designs should be better controlled for risk of bias and confounders (e.g. allocation concealment, concomitant therapies etc.). Additionally, the potential treatment effect may have been attenuated by the inclusion of participants with non‐infective bacterial causes of laryngitis; future research could also explore better ways to identify and treat those patients. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004783-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004783-sec-0022"></div> <div class="table" id="CD004783-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Fusafungine compared with no treatment for acute laryngitis in adults</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with acute laryngitis </p> <p><b>Settings:</b> ambulatory </p> <p><b>Intervention:</b> fusafungine </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> No treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Fusafungine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical cure rates at day 8 ± 1</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.07 (0.88 to 1.31)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Comparing a 7‐day course of fusafungine (6 times a day by inhalations) versus no treatment (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>778 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>832 per 1000</b> <br/> (684 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>One study with design limitations. Wide confidence interval crossing the line of no effect and small sample size. Serious imprecision and very serious risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004783-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Fusafungine plus clarithromycin compared with no treatment for acute laryngitis in adults</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with acute laryngitis </p> <p><b>Settings:</b> ambulatory </p> <p><b>Intervention:</b> fusafungine plus clarithromycin </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Fusafungine plus clarithromycin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical cure rates at day 8 ± 1</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.09 (0.90 to 1.32)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>97 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Comparing a 7‐day course of fusafungine (6 times a day by inhalations) plus clarithromycin (250 mg twice a day for 7 days) versus no treatment (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>778 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>848 per 1000</b> <br/> (700 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>One study with design limitations. Wide confidence interval crossing the line of no effect and small sample size. Serious imprecision and very serious risk of bias </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004783-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin compared with placebo for acute laryngitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with acute laryngitis </p> <p><b>Settings:</b> ambulatory </p> <p><b>Intervention:</b> erythromycin </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Erythromycin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Laryngitis at 1 week</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.10 (0.76 to 1.59)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Erythromycin 500 mg twice a day for 5 days <a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>510 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>561 per 1000</b> <br/> (387 to 811) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Laryngitis at 2 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81 (0.44 to 1.49)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>270 per 1000</b> <br/> (147 to 497) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Patients having voice disturbance at 1 week</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.87 (0.59 to1.28)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>549 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>478 per 1000</b> <br/> (324 to 703) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Patients having voice disturbance at 2 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.56 (0.28 to 1.14)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>187 per 1000</b> <br/> (93 to 380) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>One study with design limitations. Wide confidence interval crossing the line of no effect and small sample size. Serious imprecision and risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004783-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004783-sec-0023"></div> <section id="CD004783-sec-0024"> <h3 class="title" id="CD004783-sec-0024">Description of the condition</h3> <p>Upper respiratory tract infection (URTI) is the most common acute illness worldwide and is usually self diagnosed and self treated at home (<a href="./references#CD004783-bbs2-0013" title="CherryDK , BurtCW , WoodwellDA . National Ambulatory Medical Care Survey: 2001 summary. Advance Data. http://www.cdc.gov/nchs/data/ad/ad338.pdf (accessed 24 September 2003)2003; Vol. 337:1‐44. ">Cherry 2003</a>; <a href="./references#CD004783-bbs2-0037" title="McAvoyB , DavisP , RaymontA , GribbenB . The Waikato Medical Care Survey. New Zealand Medical Journal1994;107:387‐433. ">McAvoy 1994</a>). In 1995, URTI was the most frequent reason for seeking ambulatory care in the United States, resulting in more than 37 million visits to physician practitioners and emergency departments (<a href="./references#CD004783-bbs2-0020" title="GonzalesR , BartlettJG , BesserRE , HicknerJM , HoffmanJR , SandeMA , et al. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Annals of Emergency Medicine2001;37(6):698‐702. ">Gonzales 2001a</a>). It is also the most common reason for absence from work in the United States. Losses in income for employed persons, costs to employers with time lost from work and costs of medical treatment amounted to USD 112 billion in 1997 (<a href="./references#CD004783-bbs2-0010" title="BirnbaumHG , MorleyM , GreenbergPE , ColiceGL . Economic burden of respiratory infections in an employed population. Chest2002;122(2):603‐11. ">Birnbaum 2002</a>). </p> <p>Laryngeal inflammation may be due to many causes, such as viral infection, acid reflux, voice abuse, toxic inhalation, caustic ingestion, irritation from purulent sinus drainage, hypersensitivity reactions, immune disorders or from coughing due to any cause (<a href="./references#CD004783-bbs2-0030" title="KoufmanJA . Infectious and inflammatory diseases of the larynx. In: BallengerJJ , SnowJB editor(s). Otorhinolaryngology. Fifteenth. Philadelphia: Williams and Wilkins (Lea &amp; Febiger), 1996:535‐55. ">Koufman 1996</a>). </p> <p>Acute laryngitis is one of the most common pathologies identified in the larynx and can be defined as an inflammation of the larynx and vocal fold mucosa, lasting less than three weeks. Episodes are usually self limiting and are influenced by weather conditions (<a href="./references#CD004783-bbs2-0015" title="DanielidesV , NousiaCS , PatrikakosG , BartzokasA , LolisCJ , MilionisHJ , et al. Effect of meteorological parameters on acute laryngitis in adults. Acta Oto‐Laryngologica2002;122(6):655‐60. ">Danielides 2002</a>; <a href="./references#CD004783-bbs2-0053" title="VaughanCW . Current concepts in otolaryngology: diagnosis and treatment of organic voice disorders. New England Journal of Medicine1982;307(14):863‐6. ">Vaughan 1982</a>). Symptoms of acute laryngitis include a lowering of the normal pitch of the voice and hoarseness, which usually persist for three to eight days. Patients with laryngitis may also experience symptoms of an URTI, such as sore throat, odynophagia, rhinorrhoea, dyspnoea, postnasal discharge and congestion (<a href="./references#CD004783-bbs2-0043" title="PostmaGN , KoufmanJA . Laryngitis. In: BaileyBJ editor(s). Head and Neck Surgery ‐ Otolaryngology. Second Edition. Philadelphia: Lippincott‐Raven, 1998:731‐9. ">Postma 1998</a>; <a href="./references#CD004783-bbs2-0046" title="SchalenL . Acute laryngitis in adults: diagnosis, etiology, treatment. Acta Oto‐Laryngologica1988;449:31. ">Schalen 1988</a>; <a href="./references#CD004783-bbs2-0047" title="SpiegelJR , HawkshawM , MarkiewiczA , SataloffRT . Acute laryngitis. Ear, Nose, and Throat Journal2000;79(7):488. ">Spiegel 2000</a>). Direct examination with a flexible nasolaryngoscope usually reveals secretions, erythema and oedema of the vocal folds. </p> <p>Aetiology is not established in routine practice and the diagnosis can often be made by history alone. Unfortunately, there are no clinically useful criteria that help to distinguish between bacterial and viral infections (<a href="./references#CD004783-bbs2-0053" title="VaughanCW . Current concepts in otolaryngology: diagnosis and treatment of organic voice disorders. New England Journal of Medicine1982;307(14):863‐6. ">Vaughan 1982</a>). Acute infectious laryngitis is usually caused by a viral infection. Respiratory viruses like parainfluenza, rhinovirus, influenza and adenovirus have been aetiologically associated with laryngitis (<a href="./references#CD004783-bbs2-0025" title="HigginsPB . Viruses associated with acute respiratory infections 1961‐71. Journal of Hygiene1974;72(3):425‐32. ">Higgins 1974</a>; <a href="./references#CD004783-bbs2-0043" title="PostmaGN , KoufmanJA . Laryngitis. In: BaileyBJ editor(s). Head and Neck Surgery ‐ Otolaryngology. Second Edition. Philadelphia: Lippincott‐Raven, 1998:731‐9. ">Postma 1998</a>). However, bacterial pathogens such as <i>Moraxella catarrhalis</i> (<i>M. catarrhalis</i> ),<i>Haemophilus influenzae</i> (<i>H. influenzae</i> ) and <i>Streptococcus pneumoniae</i> (<i>S. pneumoniae</i>) have been frequently isolated from the nasopharynx in adults with acute laryngitis (<a href="./references#CD004783-bbs2-0027" title="HolC , SchalenC , VerduinCM , VanDijkeEE , VerhoefJ , FleerA . Moraxella catarrhalis in acute laryngitis: infection or colonization?. Journal of Infectious Diseases1996;174(3):636‐8. ">Hol 1996</a>; <a href="./references#CD004783-bbs2-0045" title="SchalenL , ChristensenP , KammeC , MiornerH , PetterssonKI , SchalenC . High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scandinavian Journal of Infectious Diseases1980;12(4):277‐80. ">Schalen 1980</a>; <a href="./references#CD004783-bbs2-0046" title="SchalenL . Acute laryngitis in adults: diagnosis, etiology, treatment. Acta Oto‐Laryngologica1988;449:31. ">Schalen 1988</a>; <a href="./references#CD004783-bbs2-0054" title="VerduinCM , HolC , FleerA , vanDijkH , vanBelkumA . Moraxella catarrhalis: from emerging to established pathogen. Clinical Microbiology Reviews2002;15(1):125‐44. ">Verduin 2002</a>); another related pathogen is <i>Chlamydia pneumoniae</i> (<i>C. pneumoniae</i>) (<a href="./references#CD004783-bbs2-0024" title="HashiguchiK , OgawaH , KazuyamaY . Seroprevalence of Chlamydia pneumoniae infections in otolaryngeal diseases. Journal of Laryngology and Otology1992;106:208. ">Hashiguchi 1992</a>). </p> </section> <section id="CD004783-sec-0025"> <h3 class="title" id="CD004783-sec-0025">Description of the intervention</h3> <p>URTIs represent one of the most common causes of antimicrobial use and a frequent reason for prescribing antibiotics in ambulatory practice and primary care (<a href="./references#CD004783-bbs2-0014" title="CohenSM , KimJ , RoyN , AscheC , CoureyM . Direct health care costs of laryngeal diseases and disorders. Laryngoscope2012;122(7):1582‐8. ">Cohen 2012</a>; <a href="./references#CD004783-bbs2-0020" title="GonzalesR , BartlettJG , BesserRE , HicknerJM , HoffmanJR , SandeMA , et al. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Annals of Emergency Medicine2001;37(6):698‐702. ">Gonzales 2001a</a>; <a href="./references#CD004783-bbs2-0037" title="McAvoyB , DavisP , RaymontA , GribbenB . The Waikato Medical Care Survey. New Zealand Medical Journal1994;107:387‐433. ">McAvoy 1994</a>; <a href="./references#CD004783-bbs2-0038" title="McCaigLF , HughesJM . Trends in antimicrobial drug prescribing among office‐based physicians in the United States. JAMA1995;273(3):214‐9. ">McCaig 1995</a>; <a href="./references#CD004783-bbs2-0049" title="SteinmanMA , LandefeldCS , GonzalesR . Predictors of broad‐spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA2003;289(6):719‐25. ">Steinman 2003a</a>; <a href="./references#CD004783-bbs2-0057" title="WHO . Upper respiratory tract infections. http://apps.who.int/medicinedocs/en/d/Js5406e/3.html (accessed 24 September 2003)2003. ">WHO 2003</a>; <a href="./references#CD004783-bbs2-0059" title="WirtzVJ , DreserA , GonzalesR . Trends in antibiotic utilization in eight Latin American countries, 1997‐2007. Revista Panamericana de Salud Pública2010;27(3):219‐25. ">Wirtz 2010</a>). In adults with acute laryngitis, treatment is usually directed toward the control of symptoms with voice rest, analgesic therapy and humidification. Macrolides, cephalosporins, a combination of penicillins with beta‐lactamase inhibitors and extended‐spectrum penicillins are also frequently prescribed (<a href="./references#CD004783-bbs2-0039" title="McGregorA , DoveyS , TilyardM . Antibiotic use in upper respiratory tract infections in New Zealand. Family Practice1995;12:166‐70. ">McGregor 1995</a>; <a href="./references#CD004783-bbs2-0049" title="SteinmanMA , LandefeldCS , GonzalesR . Predictors of broad‐spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA2003;289(6):719‐25. ">Steinman 2003a</a>). Other agents such as fusafungine oro‐nasal spray have been used for treating nasal and throat infections. Fusafungine has a bacteriostatic activity against most micro‐organisms involved in respiratory tract infections and has anti‐inflammatory properties (<a href="./references#CD004783-bbs2-0033" title="LundVJ , GrouinJM , EcclesR , BouterC , ChabolleF . Efficacy of fusafungine in acute rhinopharyngitis: a pooled analysis. Rhinology2004;42(4):207‐12. ">Lund 2004</a>). In an observational study of the antibiotic prescribing behaviour of general practitioners in managing URTIs, 14.9% of antibiotic treatment courses were prescribed for treating laryngitis or tracheitis (<a href="./references#CD004783-bbs2-0035" title="MazzagliaG , GrecoS , LandoC , CucinottaG , CaputiAP , MazzagliaG . Adult acute upper respiratory tract infections in Sicily: pattern of antibiotic drug prescription in primary care. Journal of Antimicrobial Chemotherapy1998;41(2):259‐66. ">Mazzaglia 1998</a>). A retrospective analysis for a five‐year period of 9.6 million physician office visits by patients with URTIs found that antibiotics were prescribed at more than 50% of visits (<a href="./references#CD004783-bbs2-0052" title="SunC , JewS , DastaSL . Osteopathic physicians in the United States: antibiotic prescribing practices for patients with nonspecific upper respiratory tract infections. Journal of the American Osteopathic Association2006;106(8):450‐5. ">Sun 2006</a>). </p> <p>Reasons for over‐prescribing antibiotics are varied but they often involve physicians' and patients' attitudes and expectations (<a href="./references#CD004783-bbs2-0009" title="BertinoJS . Cost burden of viral respiratory infections: issues for formulary decision makers. American Journal of Medicine2002;112(Suppl 6A):42‐9. ">Bertino 2002</a>; <a href="./references#CD004783-bbs2-0035" title="MazzagliaG , GrecoS , LandoC , CucinottaG , CaputiAP , MazzagliaG . Adult acute upper respiratory tract infections in Sicily: pattern of antibiotic drug prescription in primary care. Journal of Antimicrobial Chemotherapy1998;41(2):259‐66. ">Mazzaglia 1998</a>; <a href="./references#CD004783-bbs2-0049" title="SteinmanMA , LandefeldCS , GonzalesR . Predictors of broad‐spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA2003;289(6):719‐25. ">Steinman 2003a</a>). A Cochrane systematic review evaluated the effectiveness of professional interventions in improving antibiotic prescriptions by healthcare providers in outpatient settings as well as the impact of these interventions on reducing the incidence of antimicrobial resistant pathogens. The authors concluded that a multi‐faceted intervention, with educational interventions occurring at many levels, including repeated media campaigns, implementation of guidelines and feedback to the profession on antibiotic prescribing data and resistance, may improve antibiotic prescribing behaviour and stop the increase in the prevalence of resistant pneumococci, <i>H. influenzae</i> and other micro‐organisms (<a href="./references#CD004783-bbs2-0006" title="ArnoldSR , StrausSE . Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD003539.pub2] ">Arnold 2005</a>; <a href="./references#CD004783-bbs2-0034" title="MalmvallBE , MolstadS , DarelidJ , HiseliusA , LarssonL , SwanbergJ , et al. Reduction of antibiotics sales and sustained low incidence of bacterial resistance: report on a broad approach during 10 years to implement evidence‐based indications for antibiotic prescribing in Jonkoping County, Sweden. Quality Management in Health Care2007;16(1):60‐7. ">Malmvall 2007</a>). In addition, one study conducted in the United States found that antibiotic utilisation varies substantially among commercial health plans (<a href="./references#CD004783-bbs2-0051" title="SteinmanMA , YangKY , ByronSC , MaselliJH , GonzalesR . Variation in outpatient antibiotic prescribing in the United States. American Journal of Managed Care2009;15(12):861‐8. ">Steinman 2009</a>). </p> </section> <section id="CD004783-sec-0026"> <h3 class="title" id="CD004783-sec-0026">Why it is important to do this review</h3> <p>Concerns about the emergence and spread of antimicrobial resistance have been raised by the World Health Organization (WHO) (<a href="./references#CD004783-bbs2-0058" title="World Health Organization. Antimicrobial resistance: global report on surveillance. Available at http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf (accessed 3 February 2015)2014. ">WHO 2014</a>). The <a href="./references#CD004783-bbs2-0058" title="World Health Organization. Antimicrobial resistance: global report on surveillance. Available at http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf (accessed 3 February 2015)2014. ">WHO 2014</a> report on antimicrobial resistance observed very high rates of resistance in bacteria "that cause common health‐care associated and community‐acquired infections in all WHO regions". The excessive use of antibiotics in ambulatory practice has contributed to the emergence and spread of antibiotic‐resistant bacteria in the community, at a substantial cost to the healthcare system (<a href="./references#CD004783-bbs2-0020" title="GonzalesR , BartlettJG , BesserRE , HicknerJM , HoffmanJR , SandeMA , et al. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Annals of Emergency Medicine2001;37(6):698‐702. ">Gonzales 2001a</a>; <a href="./references#CD004783-bbs2-0021" title="GonzalesR , MaloneDC , MaselliJH , SandeMA . Excessive antibiotic use for acute respiratory infections in the United States. Clinical Infectious Disease2001;33(6):757‐62. ">Gonzales 2001b</a>; <a href="./references#CD004783-bbs2-0050" title="SteinmanMA , GonzalesR , LinderJA , LandefeldCS . Changing use of antibiotics in community‐based outpatient practice, 1991‐1999. Annals of Internal Medicine2003;138(7):525‐33. ">Steinman 2003b</a>). As the cost of medical treatment for laryngitis is high (<a href="./references#CD004783-bbs2-0010" title="BirnbaumHG , MorleyM , GreenbergPE , ColiceGL . Economic burden of respiratory infections in an employed population. Chest2002;122(2):603‐11. ">Birnbaum 2002</a>; <a href="./references#CD004783-bbs2-0014" title="CohenSM , KimJ , RoyN , AscheC , CoureyM . Direct health care costs of laryngeal diseases and disorders. Laryngoscope2012;122(7):1582‐8. ">Cohen 2012</a>), and there is increasing concern over the resistance of common bacteria to commonly used antibiotics, there is a need to investigate the role of antibiotic drugs in acute laryngitis. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004783-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004783-sec-0027"></div> <p>To assess the effectiveness and safety of different antibiotic therapies in adults with acute laryngitis. A secondary objective was to report the rates of adverse events associated with these treatments. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004783-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004783-sec-0028"></div> <section id="CD004783-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004783-sec-0030"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) comparing antibiotic therapy with placebo or another antibiotic in the treatment of acute laryngitis. </p> </section> <section id="CD004783-sec-0031"> <h4 class="title">Types of participants</h4> <p>We included adults with acute laryngitis, defined by the International Classification of Health Problems in Primary Care (ICHPPC) as hoarseness associated with other symptoms of URTI. We excluded participants with relevant chronic underlying diseases, those displaying symptoms of laryngitis for more than three weeks (chronic laryngitis) and those receiving antibiotic therapy within the two weeks preceding diagnosis. </p> </section> <section id="CD004783-sec-0032"> <h4 class="title">Types of interventions</h4> <p>We included trials comparing antibiotics with placebo or antibiotics of a different class for acute laryngitis. </p> </section> <section id="CD004783-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD004783-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004783-list-0001"> <li> <p>Clinical improvement</p> <ol id="CD004783-list-0002"> <li> <p>Improvement in recorded voice score assessed by an expert panel at presentation and after the period of time considered in each trial (usually one or two weeks, or both). As a standard, trials used the patient's normal voice, recorded weeks later. </p> </li> <li> <p>Symptom improvement at presentation (hoarseness/subjective voice score, pharyngitis, cough, sore throat and rhinorrhoea/nasal congestion) and after the period of time considered in each trial, as assessed by the investigators or the patient. </p> </li> </ol> </li> </ol> </p> </section> <section id="CD004783-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004783-list-0003"> <li> <p>Bacteriological findings</p> <ol id="CD004783-list-0004"> <li> <p>Evaluated at the acute and follow‐up visits.</p> </li> </ol> </li> <li> <p>Adverse reactions following antibiotic therapy</p> <ol id="CD004783-list-0005"> <li> <p>Serious adverse events, i.e. serious enough to require withdrawal from the treatment group. </p> </li> <li> <p>Minor adverse events reported by participants and not requiring withdrawal from the treatment group (gastrointestinal side effects such as diarrhoea, dyspepsia, abdominal pain and rash). </p> </li> </ol> </li> <li> <p>Laryngoscopic findings</p> <ol id="CD004783-list-0006"> <li> <p>Evaluated at the acute and follow‐up visits.</p> </li> </ol> </li> </ol> </p> </section> </section> </section> <section id="CD004783-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004783-sec-0037"> <h4 class="title">Electronic searches</h4> <p>For this 2014 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL 2014, Issue 11) (accessed 16 December 2014), which includes the Cochrane Acute Respiratory Infections (ARI) Group's Specialised Register, MEDLINE (January 2013 to November week 3, 2014), EMBASE (January 2013 to December 2014), LILACS (January 2013 to December 2014) and BIOSIS (January 2013 to December 2014). </p> <p>The CENTRAL and MEDLINE search strategies are in <a href="./appendices#CD004783-sec-0095">Appendix 1</a>. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision); Ovid format (<a href="./references#CD004783-bbs2-0031" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefevbre 2011</a>). We adapted the search strategy to search EMBASE (<a href="./appendices#CD004783-sec-0097">Appendix 2</a>), LILACS (<a href="./appendices#CD004783-sec-0098">Appendix 3</a>) and BIOSIS (<a href="./appendices#CD004783-sec-0099">Appendix 4</a>). Details of earlier searches are in <a href="./appendices#CD004783-sec-0100">Appendix 5</a>. </p> <p>We imposed no language or publication restrictions.</p> </section> <section id="CD004783-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We employed other strategies including the searching of references of review articles and books related to infections of the respiratory tract, and handsearches of journals such as <i>Journal of Infectious Diseases</i> ,<i>Clinical Infectious Diseases</i> ,<i>Journal of Antimicrobial Chemotherapy</i> ,<i>Head and Neck</i> ,<i>Otorhinolaryngology</i> ,<i>Annals of Otology Rhinology and Laryngology</i> and<i>Scandinavian Journal of Infectious Diseases</i> (for the 2008 update). </p> <p>We searched grey literature such as conference abstracts/proceedings, published lists of theses and dissertations worldwide (dissertation abstract database), letters, government documents (CDC database) and other literature outside of the main journal literature, where possible (<a href="./references#CD004783-bbs2-0036" title="McAuleyL , PhamB , TugwellP , MoherD . Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta‐analyses?. Lancet2000;356:1228‐31. ">McAuley 2000</a>). </p> <p>We contacted some pharmaceutical companies to obtain unpublished trial data. We contacted leading researchers involved in the field by e‐mail to obtain information on additional published and unpublished data and trials (for the 2008 update). </p> <p>We also consulted local and international experts in the field and searched databases of ongoing trials registers such as the International Clinical Trials Registry Platform (ICTRP) search portal (<a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">http://www.who.int/trialsearch/Default.aspx</a>) using the following terms: acute laryngitis. </p> </section> </section> <section id="CD004783-sec-0039"> <h3 class="title" id="CD004783-sec-0039">Data collection and analysis</h3> <section id="CD004783-sec-0040"> <h4 class="title">Selection of studies</h4> <p>Two review authors (LR, AC) independently retrieved the articles and assessed their eligibility from the title and abstracts. </p> </section> <section id="CD004783-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (LR, AC) independently assessed the full text of all studies identified as possibly relevant. The review authors were not blinded to the origin or conclusions of the article during eligibility assessment, data extraction or quality assessment (<a href="./references#CD004783-bbs2-0008" title="BerlinJ . Does blinding readers affect the results of meta‐analysis? University of Pennsylvania Meta‐analysis Blinding Study Group. Lancet1997;350:185‐6. ">Berlin 1997</a>). </p> </section> <section id="CD004783-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LR, AC) independently assessed the risk of bias for each study as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004783-bbs2-0026" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Chichester, UK: Wiley‐Blackwell, 2011. ">Higgins 2011</a>). We resolved disagreements by discussion. The possible sources of bias described below are considered and reflected in the 'Risk of bias' table for each included study. Whenever possible we included additional information with a clarifying comment or a quoted sentence taken directly from the original article. </p> <p>We assessed the following domains as low risk of bias, unclear or high risk of bias:</p> <p> <ol id="CD004783-list-0007"> <li> <p>Generation of allocation sequence</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding (of participants, personnel and outcome assessors)</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective reporting</p> </li> <li> <p>Other sources</p> </li> </ol> </p> <section id="CD004783-sec-0043"> <h5 class="title">(1) Generation of allocation sequence (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as follows.</p> <p> <ul id="CD004783-list-0008"> <li> <p>Low risk (any truly random process, e.g. random number table; computer random number generator). </p> </li> <li> <p>High risk (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Unclear risk, if the trial was described as randomised, but the method used for the allocation sequence generation was not described.    </p> </li> </ul> </p> </section> <section id="CD004783-sec-0044"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal the allocation sequence in sufficient detail to determine whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as follows.</p> <p> <ul id="CD004783-list-0009"> <li> <p>Low risk (e.g. telephone or central randomisation; consecutively numbered, sealed, opaque envelopes). </p> </li> <li> <p>High risk (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth). </p> </li> <li> <p>Unclear risk, if the trial was described as randomised, but the method used to conceal the allocation was not described. </p> </li> </ul> </p> </section> <section id="CD004783-sec-0045"> <h5 class="title">(3) Blinding or masking (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We judged studies at low risk of bias if they were blinded, or if we judged that the lack of blinding could not have affected the results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as follows.</p> <p> <ul id="CD004783-list-0010"> <li> <p>Low risk, high risk or unclear for participants.</p> </li> <li> <p>Low risk, high risk or unclear for personnel.</p> </li> <li> <p>Low risk, high risk or unclear for outcome assessors.</p> </li> </ul> </p> </section> <section id="CD004783-sec-0046"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, drop‐outs, protocol deviations) </h5> <p>We assessed the methods as follows.</p> <p> <ul id="CD004783-list-0011"> <li> <p>Low risk (any one of the following): no missing outcome data; reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias); missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups; for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate; for continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size; missing data have been imputed using appropriate methods. </p> </li> </ul> <ul id="CD004783-list-0012"> <li> <p>High risk (any one of the following): reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups; for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate; for continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size; 'as‐treated' analysis done with substantial departure of the intervention received from that assigned at randomisation; potentially inappropriate application of simple imputation. </p> </li> </ul> <ul id="CD004783-list-0013"> <li> <p>Unclear risk (any one of the following): insufficient reporting of attrition/exclusions to permit judgement of 'low risk' or 'high risk' (e.g. number randomised not stated, no reasons for missing data provided); the study did not address this outcome. </p> </li> </ul> </p> </section> <section id="CD004783-sec-0047"> <h5 class="title">(5) Selective reporting bias (reporting bias due to selective outcome reporting)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as follows.</p> <p> <ul id="CD004783-list-0014"> <li> <p>Low risk (any one of the following): the study protocol is available and all of the study's pre‐specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre‐specified way or the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified (convincing text of this nature may be uncommon). </p> </li> </ul> <ul id="CD004783-list-0015"> <li> <p>High risk (any one of the following): not all of the study's pre‐specified primary outcomes have been reported; one or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre‐specified; one or more reported primary outcomes were not pre‐specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect); one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta‐analysis; the study report fails to include results for a key outcome that would be expected to have been reported for such a study. </p> </li> </ul> <ul id="CD004783-list-0016"> <li> <p>Unclear risk: insufficient information to permit judgement of 'low risk' or 'high risk'. </p> </li> </ul> </p> </section> <section id="CD004783-sec-0048"> <h5 class="title">(6) Free of other bias (bias due to problems not covered elsewhere in the table)</h5> <p>We described for each included study any important concerns we have about other possible sources of bias (baseline imbalance, sponsorship bias, confirmation bias, bias of the presentation data, etc.) </p> <p> <ul id="CD004783-list-0017"> <li> <p>Low risk of bias: the trial appears to be free of other components that could put it at risk of bias. </p> </li> <li> <p>Unclear risk: the trial may or may not be free of other components that could put it at risk of bias. </p> </li> <li> <p>High risk of bias: there are other factors in the trial that could put it at risk of bias, e.g. no sample size calculation made, academic fraud, industry involvement or extreme baseline imbalance. </p> </li> </ul> </p> </section> <section id="CD004783-sec-0049"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004783-bbs2-0026" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Chichester, UK: Wiley‐Blackwell, 2011. ">Higgins 2011</a>). Two review authors independently carried out data extraction using a previously designed form to ensure validity. Discrepancies were resolved by an open discussion between all review authors. The differences in the study participants, interventions and outcomes among the included trials are presented in the <a href="./references#CD004783-sec-0117" title="">Characteristics of included studies</a> table. </p> <p>We used the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach to assess the quality of the body of evidence as related to the following outcomes (<a href="./references#CD004783-bbs2-0023" title="GuyattGH , OxmanAD , SantessoN , HelfandM , VistG , KunzR , et al. GRADE guidelines: 12. Preparing summary of findings tables‐binary outcomes. Journal of Clinical Epidemiology2013;66(2):158‐72. ">Guyatt 2013</a>). </p> <p> <ul id="CD004783-list-0018"> <li> <p>Clinical cure rates</p> </li> </ul> </p> <p>We used Review Manager 5.3 to create 'Summary of findings' tables (<a href="./references#CD004783-bbs2-0044" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We produced a summary of the intervention effect and a measure of quality for each of the above outcomes using the GRADE approach. The GRADE approach is based on five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias), which are used to assess the quality of the body of evidence for each outcome. Evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias (<a href="./references#CD004783-bbs2-0023" title="GuyattGH , OxmanAD , SantessoN , HelfandM , VistG , KunzR , et al. GRADE guidelines: 12. Preparing summary of findings tables‐binary outcomes. Journal of Clinical Epidemiology2013;66(2):158‐72. ">Guyatt 2013</a>). </p> </section> </section> <section id="CD004783-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>We assessed the measurement of the intervention effect for dichotomous outcomes using the risk ratio (RR). We assessed the measurement of the intervention effect for continuous outcomes using the mean difference (MD). </p> </section> <section id="CD004783-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>We found no studies with non‐standard designs, such as cross‐over trials and cluster‐randomised trials. </p> </section> <section id="CD004783-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>In future updates, we will address missing data for dichotomous outcomes by an intention‐to‐treat (ITT) analysis. We will consider the potential impact of these missing data in the interpretation of the results of the review when necessary. </p> </section> <section id="CD004783-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>In future updates, we will assess heterogeneity using the I<sup>2</sup> statistic. We will interpret the I<sup>2</sup> statistic according to the following thresholds: less than 25% will be considered as low level heterogeneity; 25% to 50% as moderate level; and higher than 50% as high level heterogeneity (<a href="./references#CD004783-bbs2-0026" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Chichester, UK: Wiley‐Blackwell, 2011. ">Higgins 2011</a>). </p> <p>We will explore potential sources of heterogeneity by means of a subgroup analysis when possible. </p> </section> <section id="CD004783-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>For future updates, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually and use formal tests for funnel plot asymmetry (<a href="./references#CD004783-bbs2-0026" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Chichester, UK: Wiley‐Blackwell, 2011. ">Higgins 2011</a>). </p> </section> <section id="CD004783-sec-0055"> <h4 class="title">Data synthesis</h4> <p>For future updates, we will use fixed‐effect meta‐analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect, i.e. where trials are examining the same intervention and the trials' populations and methods are judged sufficiently similar. We will use a random‐effects meta‐analysis if clinical heterogeneity is sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, to produce an overall summary if an average treatment effect across trials is considered clinically meaningful. We will treat the random‐effects summary as the average range of possible treatment effects. If we use random‐effects analyses, we will present the results as the average treatment effect with its 95% confidence interval, and the estimates of the T<sup>2</sup> and I<sup>2</sup> statistic (<a href="./references#CD004783-bbs2-0026" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Chichester, UK: Wiley‐Blackwell, 2011. ">Higgins 2011</a>). </p> </section> <section id="CD004783-sec-0056"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>For future updates, we will perform subgroup analysis in order to investigate heterogeneity by studying the factors that contribute to clinical heterogeneity. We will perform subgroup analyses according to gender, age and different doses of antibiotics administered. </p> </section> <section id="CD004783-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>For future updates, we plan to carry out a sensitivity analyses according to 'Risk of bias' assessment (<a href="./references#CD004783-bbs2-0026" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane‐handbook.org. Chichester, UK: Wiley‐Blackwell, 2011. ">Higgins 2011</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004783-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004783-sec-0058"></div> <section id="CD004783-sec-0059"> <h3 class="title">Description of studies</h3> <section id="CD004783-sec-0060"> <h4 class="title">Results of the search</h4> <p>This is an updated version of the original review published in Issue 1, 2005 of <i>The Cochrane Library</i> (<a href="./references#CD004783-bbs2-0061" title="ReveizL , CardonaAF , OspinaEG . Antibiotics for acute laryngitis in adults. Cochrane Database of Systematic Reviews2005, Issue 1. [DOI: 10.1002/14651858.CD004783.pub2] ">Reveiz 2005</a>)<i>.</i> From the results of the extensive literature searches, we initially identified 3610 citations as potentially relevant. We performed updated searches from June 2004 to December 2006, from December 2006 to November 2008, from October 2008 to February 2011, from January 2011 to January 2013 and from January 2013 to December 2014, resulting in 263 additional citations. Manual culling reduced this to four reports of possibly eligible trials. Only three trials fulfilled the criteria for inclusion (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>; <a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>; <a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>), and we excluded a duplicated trial (<a href="./references#CD004783-bbs2-0004" title="SchalénL , EliassonI , FexS , KammeC , SchalenC . Acute laryngitis in adults: results of erythromycin treatment. Acta Oto‐Laryngologica. Supplement1992;492:55‐7. ">Schalén 1992</a>). <a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a> and <a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a> were conducted by the same group of researchers in Sweden and <a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a> was conducted in Russia. Additional searches conducted to identify other relevant studies or unpublished data did not uncover any new trials. Although we identified 32 trials in the ICTRP database (December 2014), no ongoing trials complied with the inclusion criteria. </p> </section> <section id="CD004783-sec-0061"> <h4 class="title">Included studies</h4> <p>In a study of penicillin V in acute laryngitis in adults (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>), 100 participants over 18 years of age were examined and recruited at the otolaryngology department of the University of Lund, Sweden to receive either penicillin V (800 mg two times a day for five days) or an identical placebo. No participants were reported to have dropped out or as having been lost to follow‐up. Exclusion criteria included participants with relevant underlying diseases such as chronic bronchitis, pregnancy, antibiotic treatment within the preceding two weeks and a history of penicillin allergy. </p> <p>The trial measured the symptoms of hoarseness (subjective voice score), cough, rhinorrhoea and nasal congestion using self reported daily records collected in a questionnaire. At the acute visit, indirect laryngoscopy revealed laryngeal signs of inflammation in 97% of the cases (not conclusive in three cases due to intense throat reflexes)). A voice recording of standardised text was obtained for each patient at the first visit and subsequently at re‐examinations at five to seven days, 10 to 14 days, and two to six months following the acute episode. The four recordings from each patient were presented in random order to four experienced voice specialists. The voice samples were evaluated with regards to 10 different qualities of voice (no further description of the quality of voice was provided). Each quality was evaluated individually by the members of the group using a quantitative score (0 = normal, 1 = slight aberration, 2 = abnormal) and the sum of each result was used to obtain an average score for the penicillin V and placebo groups. Microbiological specimens were collected from the nasopharynx and throat at the initial visit and one and two weeks later. </p> <p>The second trial investigated erythromycin for the treatment of acute laryngitis in adults (<a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>). One hundred and six consecutive participants were recruited at the otolaryngology department of the University of Lund, Sweden, and 90 completed the double‐blind trial. Six participants failed to keep scheduled appointments and one presented with an exanthema on the second day of antibiotic treatment. Participants lost to follow‐up were not included in the analysis. Participants were randomised to receive either erythromycin ethylsuccinate (taken orally twice daily for five days) or placebo in identical tablets. The inclusion and exclusion criteria, outcomes and follow‐up were the same as the first trial. However, a different voice score (0 = normal, 1 = slight aberration, 2 = moderate aberration, 3 = severe aberration) and 12 voice qualities (rough voice, diplophonia, breathiness, vocal fry, episodes of aphonia, registered abnormalities, registered breaks, sonority, hyperfunction and hypofunction, and high or low pitch) were used in the second trial. </p> <p>The trial from Russia was reported as an abstract at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); a full report was not available from a peer‐reviewed journal (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>), and although efforts were made to contact the trial authors, we obtained no further information. The study included 145 adult patients with symptoms of acute laryngitis. However, no further eligibility criteria were provided. Participants were randomised to three groups of treatment: Group 1: seven‐day course of fusafungine (Bioparox®, Servier) (six times a day by inhalations); Group 2: seven‐day course of fusafungine (Bioparox®, Servier) (six times a day by inhalations) plus clarithromycin (Clacid®, Abbott) (250 mg twice a day for seven days); and Group 3: no treatment. Clinical cure rates were measured at days 5 ± 1, 8 ± 1 and 28 ± 2. </p> </section> <section id="CD004783-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We excluded only one study from the review (see <a href="./references#CD004783-sec-0118" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD004783-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>We considered studies to have moderate to high risk of bias (see <a href="#CD004783-sec-0063">Risk of bias in included studies</a>, <a href="#CD004783-fig-0001">Figure 1</a> and <a href="#CD004783-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD004783-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD004783-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD004783-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study" data-id="CD004783-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <p>In the penicillin V study (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>), methods to generate the sequence of randomisation and allocation concealment were not reported. Furthermore, no description of the sample size or power calculation was recorded. Both the participants and treating physicians were blinded. However, the characteristics of this blinding were not described. No drop‐outs or withdrawals were reported. </p> <p>Information was given regarding baseline characteristics including gender, age, voice demand or abuse, smoker condition and previous laryngitis (three or more episodes during the preceding five years) making it easy to ascertain that the groups were sufficiently similar at the start of the trial. There were no statistically significant differences between the two groups in symptoms and clinical findings at the acute visits (in terms of preceding URTI, presence of rhinitis, cough and sore throat, abnormal findings like redness and oedema in the larynx, pharynx and epipharynx, mean voice score and bacterial pathogen isolated from the nasopharynx). </p> <p>The mean interval between the start of vocal symptoms and the first evaluation was 3.6 days. However, the interval was longer for participants receiving antibiotics (3.8 ± 3.3) compared to the placebo (3.4 ± 3.0). All data were evaluated using a cross‐tabulated Chi<sup>2</sup> test and a probability level of 0.01 was considered significant. </p> <p>The erythromycin study publication, <a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>, stated that the trial was randomised and participants and physicians were blinded by using identical placebo tablets. A power calculation and intention‐to‐treat (ITT) analysis were not reported. Seven of 106 participants dropped out or withdrew from the study for specific reasons and were not accounted for in the trial analysis. Baseline characteristics of the participants appeared to be broadly similar between groups and included the same variables as the penicillin V study. As they were not described, we calculated P values for any differences in the population characteristics and the symptoms and signs at presentation and found no significant difference between the two groups. </p> <p>The erythromycin group had a significantly higher proportion of bacterial pathogens and <i>M. catarrhalis</i> was isolated from the nasopharynx in this group (P value = 0.045 and P value = 0.012, Fisher's exact test), respectively. The mean interval between the start of vocal symptoms and the first evaluation was not reported. Non‐parametric tests were used for statistical analysis. Fisher's exact probability test was used to compare bacterial elimination rates between the two groups and the Mann‐Whitney U test with adjusted z was used for all other comparisons. A probability level of 5% was considered significant. </p> <p>In the open trial from Russia the methods used to generate the sequence of randomisation and allocation concealment were not reported (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>). Information on relevant prespecified outcomes and baseline characteristics was not provided. </p> <section id="CD004783-sec-0064"> <h4 class="title">Allocation</h4> <p>We judged the methods of randomisation and allocation concealment to be unclear in all RCTs. </p> </section> <section id="CD004783-sec-0065"> <h4 class="title">Blinding</h4> <p>Both trials from Sweden were reported as "double blind". However, it was unclear if the methods to ensure blinding were effective. There was insufficient information to permit judgement of 'low risk' or 'high risk' on blinding of participants and personnel and blinding of the outcome assessment. The trial from Russia had an open design and we judged it as having high risk of bias (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>). </p> </section> <section id="CD004783-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>One trial had no drop‐outs and we judged it as having low risk of bias (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>). In another trial, 15% of participants were lost to follow‐up and we judged it as having unclear risk of bias (<a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>). No participants were reported as having been lost to follow‐up at days five and eight in the <a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a> trial. However, 72% of participants did not provide data at day 28. </p> </section> <section id="CD004783-sec-0067"> <h4 class="title">Selective reporting</h4> <p>We judged both Swedish trials as having unclear risk of bias. The <a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a> trial did not provide detailed information on the improvement in recorded voice score, specific adverse events, or bacteriological or laryngoscopic findings and we judged it as having high risk of bias. </p> </section> <section id="CD004783-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>Other potential sources of bias are summarised in the 'Risk of bias' tables. No report on coadjuvant medication was provided in the <a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a> trial. </p> </section> </section> <section id="CD004783-sec-0069"> <h3 class="title" id="CD004783-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD004783-tbl-0001"><b>Summary of findings for the main comparison</b> </a>; <a href="./full#CD004783-tbl-0002"><b>Summary of findings 2</b> </a>; <a href="./full#CD004783-tbl-0003"><b>Summary of findings 3</b> </a> </p> <section id="CD004783-sec-0070"> <h4 class="title">Primary outcomes</h4> <section id="CD004783-sec-0071"> <h5 class="title">1. Clinical improvement</h5> <section id="CD004783-sec-0072"> <h6 class="title">A. Improvement in recorded voice score</h6> <p>In the penicillin V trial the mean objective voice scores at the first visit and at re‐examination after one and two weeks, as well as at follow‐up after two to six months, did not differ significantly between the penicillin V and the placebo groups (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>). Significant improvement was reported in the severity of reported vocal symptoms, nasal congestion/rhinorrhoea, throat symptoms, cough and laryngeal abnormalities evaluated by indirect laryngoscopy at the follow‐up examinations in the control and intervention groups, as judged by the participants. Significant improvement measured by higher mean voice scores was found at the acute visits among participants with <i>M. catarrhalis</i> , <i>H. influenzae</i> or <i>S. pneumoniae</i> (26 ± 8) isolated from the nasopharynx, compared to results obtained for those with negative cultures (20 ± 10) (P value &lt; 0.05). However, the subjective voice scores at the acute visits did not differ between the participants harbouring the three mentioned pathogen isolates and those without the organisms. This study used parametric measures. Data were not available to calculate estimates. </p> <p>In the erythromycin trial the mean objective voice scores at the first visit, at re‐examination after one and two weeks, and at follow‐up after two to six months, did not differ significantly between control and intervention groups (<a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>). Thirty randomly selected voice samples recorded at presentation were evaluated and the Kendall coefficient of concordance between listeners for the voice qualities ranged from 0.45 to 0.91. (The Kendall's coefficient of concordance is a measure of the agreement among several judges who are assessing a given set of objects). After one week, the mean scores were clearly reduced and the voice profiles were essentially normalised in both groups. </p> </section> <section id="CD004783-sec-0073"> <h6 class="title">B. Symptom improvement at presentation</h6> <p>In the <a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a> trial, the authors reported no significant differences when comparing fusafungine versus fusafungine plus clarithromycin at days 5 ± 1, 8 ± 1 and 28 ± 2 (<a href="./references#CD004783-fig-0003" title="">Analysis 1.1</a>; <a href="./references#CD004783-fig-0004" title="">Analysis 1.2</a>; <a href="./references#CD004783-fig-0005" title="">Analysis 1.3</a>). However, significant differences were reported in the rates of clinical cure at day 5 ± 1 favouring fusafungine (one trial; 93 participants; RR 1.50, 95% CI 1.02 to 2.20; <a href="./references#CD004783-fig-0007" title="">Analysis 2.1</a>) and fusafungine plus clarithromycin (one trial, 97 participants; RR 1.47, 95% CI 1.00 to 2.16; <a href="./references#CD004783-fig-0010" title="">Analysis 3.1</a>) when compared to no treatment. Additionally, no significant differences were found at days 8 ± 1 and 28 ± 2 in the rates of clinical cure for both comparison (<a href="./references#CD004783-fig-0008" title="">Analysis 2.2</a>; <a href="./references#CD004783-fig-0009" title="">Analysis 2.3</a>; <a href="./references#CD004783-fig-0011" title="">Analysis 3.2</a>; <a href="./references#CD004783-fig-0012" title="">Analysis 3.3</a>) or in the rate of adverse events when comparing fusafungine versus fusafungine plus clarithromycin (<a href="./references#CD004783-fig-0006" title="">Analysis 1.4</a>). </p> <p>There were no significant differences in the clinical examinations after one and two weeks in the presence of resolution of laryngitis (one trial, 99 participants; risk ratio (RR) 1.10, 95% confidence interval (CI) 0.76 to 1.59 (<a href="./references#CD004783-fig-0013" title="">Analysis 4.1</a>) and RR 0.81, 95% CI 0.44 to 1.49 (<a href="./references#CD004783-fig-0014" title="">Analysis 4.2</a>), respectively). In addition, although there was a significant improvements in the rate of patients having voice disturbance at week one when comparing erythromycin and placebo groups as judged by the participants (one trial, 99 participants, RR 0.64, 95% CI 0.46 to 0.90 (<a href="./references#CD004783-fig-0017" title="">Analysis 4.5</a>) no significant difference was found at week two (RR 0.56, 95% CI 0.28 to 1.14 (<a href="./references#CD004783-fig-0018" title="">Analysis 4.6</a>)). However, comparing the erythromycin and placebo groups significant improvements were found in the severity of reported vocal symptoms as judged by the participants. </p> <p>While significantly fewer complaints of cough were reported by the erythromycin group compared to the placebo group at week two (one trial, 99 participants; RR 0.38, 95% CI 0.15 to 0.97; <a href="./references#CD004783-fig-0020" title="">Analysis 4.8</a>), no difference was found at week one (<a href="./references#CD004783-fig-0019" title="">Analysis 4.7</a>). The trialists also compared signs pharyngitis and rhinitis, evaluated by mirror endoscopy or direct inspection, and found no statistical differences between the two groups. </p> <p>We did not aggregate results from the trials as there was significant heterogeneity between them, with different drugs and definitions of some outcomes. </p> </section> </section> </section> <section id="CD004783-sec-0074"> <h4 class="title">Secondary outcomes</h4> <section id="CD004783-sec-0075"> <h5 class="title">1. Bacteriological findings</h5> <p>In the penicillin V trial <i>M. catarrhalis</i> ,<i>H. influenzae</i> and <i>S. pneumoniae</i> were isolated from 50%, 15% and 1% of the participants respectively, at the first evaluation (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>). The isolation rates of each of the mentioned pathogens at the acute and follow‐up visits did not differ significantly between the two intervention groups. </p> <p>In the erythromycin trial <i>M. catarrhalis</i> was isolated from the nasopharynx in 50% of participants, <i>H. influenzae</i> in 20% of participants and <i>S. pneumoniae</i> in 5% of participants at the acute visit (<a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>). After one week, <i>M. catarrhalis</i> was eliminated in 83% of the participants in the erythromycin group as compared with 32% in the placebo group (one trial, 49 participants; RR 2.64, 95% CI 1.34 to 5.21; <a href="./references#CD004783-fig-0015" title="">Analysis 4.3</a>). However, there was no difference between the two groups in the recovery rate of <i>M. catarrhali</i>s at two weeks (<a href="./references#CD004783-fig-0016" title="">Analysis 4.4</a>). </p> </section> <section id="CD004783-sec-0076"> <h5 class="title">2. Adverse reactions following antibiotic therapy</h5> <section id="CD004783-sec-0077"> <h6 class="title">A. Serious adverse events</h6> <p>No deaths were reported in either the penicillin V trial (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>) or the erythromycin study (<a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>). No adverse drug reactions were reported in the penicillin V trial (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>), although it was unclear which potential toxic effects were monitored for. </p> </section> <section id="CD004783-sec-0078"> <h6 class="title">B. Minor adverse events reported by participants</h6> <p>Only one patient was reported to present with an exanthema, on the second day of erythromycin treatment. The frequency of adverse events was not significantly different between the fusafungine versus fusafungine plus clarithromycin groups (one trial; 100 participants; RR 0.81, 95% CI 0.19 to 3.45; <a href="./references#CD004783-fig-0006" title="">Analysis 1.4</a>) (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>). </p> </section> </section> <section id="CD004783-sec-0079"> <h5 class="title">3. Laryngoscopic findings</h5> <p>None of the studies reported the outcome laryngoscopic findings.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004783-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004783-sec-0080"></div> <section id="CD004783-sec-0081"> <h3 class="title" id="CD004783-sec-0081">Summary of main results</h3> <p>Overall, the available evidence is of poor quality and antibiotics did not improve objective outcome measures in patients with acute laryngitis. Erythromycin could reduce voice disturbance at one week and cough at two weeks when measured subjectively. In the more recently included trial, fusafungine or fusafungine plus clarithromycin were more effective than no treatment in patients with acute laryngitis at day five, but no significant differences were found at days eight and 28 (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>). However, no significant differences were found when adding clarithromycin to fusafungine. In addition, we judged this study, which was presented as an abstract in a conference, as having high risk of bias for many domains of the 'Risk of bias' tool. We consider that these findings are not sufficient to justify the use of antibiotics in clinical practice. Treating laryngitis with conservative measures in the first instance is reasonable as it remains unclear that antibiotics are worthy and beneficial to individuals or populations, particularly in the context of antimicrobial resistance (<a href="./references#CD004783-bbs2-0058" title="World Health Organization. Antimicrobial resistance: global report on surveillance. Available at http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf (accessed 3 February 2015)2014. ">WHO 2014</a>). </p> <section id="CD004783-sec-0082"> <h4 class="title">Benefits of treatment</h4> <p>The effectiveness of antibiotic treatment for the common cold and for sore throat is covered in other Cochrane Reviews (<a href="./references#CD004783-bbs2-0007" title="ArrollB , KenealyT . Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD000247.pub3] ">Arroll 2013</a>; <a href="./references#CD004783-bbs2-0048" title="SpinksA , GlasziouPP , DelMarC . Antibiotics for sore throat. Cochrane Database of Systematic Reviews2013, Issue 11. [DOI: 10.1002/14651858.CD000023.pub4] ">Spinks 2013</a>). Trials identified in those reviews included some participants with symptoms of acute laryngitis; conditions that affect the upper respiratory tract are not a single entity. Acute laryngitis may result from direct infection of the larynx, from irritation of the larynx due to coughing or from contact with infected secretions. Hence the supposition that acute laryngitis, along with other conditions that affect the upper respiratory tract, may not be related to one particular cause. As mentioned by Arroll et al, the review authors had to accept the clinical judgement of the trialists as to which participants were included in their upper respiratory tract infection (URTI) clinical trials (<a href="./references#CD004783-bbs2-0007" title="ArrollB , KenealyT . Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database of Systematic Reviews2013, Issue 6. [DOI: 10.1002/14651858.CD000247.pub3] ">Arroll 2013</a>). </p> <p>Erythromycin is apparently effective at reducing voice disturbances as measured by participants after one week and cough after two weeks. The authors considered that these findings suggested the usefulness of antibiotics in a special subgroup of people for whom voice function was essential to their professional or social activities, but their use appeared to be discretionary rather than mandatory. We calculated a risk ratio (RR) of 0.64 (95% confidence interval (CI) 0.46 to 0.90, P value = 0.034) with a number needed to treat for an additional beneficial outcome (NNTB) of 3.76 (95% CI 2.27 to 13.52; P value = 0.01) for the subjective voice scores at one week, considering total improvement as score '0' and partial or no improvement as the sum of scores 1, 2 and 3; for cough after two weeks the RR was 0.38 (95% CI 0.15 to 1, P value = 0.058). Conversely, a lack of improvement in subjective measures was found with the use of penicillin V (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>).  </p> <p>In the <a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a> trial, adding clarithromycin to fusafungine did not show any significant difference in the rates of cured patients. When comparing fusafungine to no treatment at day 5 ± 1, we calculated a NNTB of 4.5 for the clinical cure outcome. </p> <p>Acute laryngitis is a self limiting condition that usually varies in duration from three to eight days. Considering that the time taken from the start of hoarseness to the visit reported in the penicillin V trial was 3.6 (± 3.2) days (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>), most of the first re‐examinations would have been done five to seven days later, when symptoms were likely to have disappeared. Outcomes such as reduction of illness time and absolute reduction averaged over the whole illness were not estimated in the present trials. These clinically important outcomes and other outcomes, such as re‐attendance or time off school or work, are probably at least as important as those that were used. It is important to state that the use of the voice score attempts to qualify different signs in a quantitative manner. This implies some subjectivity in assessing each score. Furthermore, the trial authors assumed that any difference from zero to one, or from one to two, was equally relevant, and the 10 (or 12) signs analysed were also considered equally important (<a href="./references#CD004783-bbs2-0005" title="AltmanDG . Types of data. In: AltmanDG editor(s). Practical Statistics for Medical Research. Eighth. Chapman &amp; Hall/CRC, 1999:10‐18. ">Altman 1999</a>). </p> <p>The Swedish trials only included people with laryngitis who were admitted to the ear, nose and throat department, which may have led to selection bias that favoured participants with severe symptoms. People with this condition will often not go to hospital or consult a primary care practitioner (<a href="./references#CD004783-bbs2-0013" title="CherryDK , BurtCW , WoodwellDA . National Ambulatory Medical Care Survey: 2001 summary. Advance Data. http://www.cdc.gov/nchs/data/ad/ad338.pdf (accessed 24 September 2003)2003; Vol. 337:1‐44. ">Cherry 2003</a>; <a href="./references#CD004783-bbs2-0037" title="McAvoyB , DavisP , RaymontA , GribbenB . The Waikato Medical Care Survey. New Zealand Medical Journal1994;107:387‐433. ">McAvoy 1994</a>). Another concern was information not collected by the trial authors, such as the concomitant use of other medications that may alter the course of illness, for example, decongestants, heated or humidified air, or voice rest, etc. </p> </section> <section id="CD004783-sec-0083"> <h4 class="title">Adverse effects of treatment</h4> <p>Reporting on the adverse effects of antibiotic use was irregular. Other studies have described rare but severe adverse reactions, for example, hepatotoxicity, transient deafness and allergic reactions. Gastrointestinal symptoms represented the most frequent disturbance, occurring in 15% to 20% of participants on erythromycin. A significant number of drug interactions have also been reported (<a href="./references#CD004783-bbs2-0018" title="FDA . PCE® (erythromycin particles in tablets). Available at: http://www.fda.gov/medwatch/SAFETY/2004/mar_PI/PCE_PI.pdf (accessed July 2004). ">FDA 2004</a>; <a href="./references#CD004783-bbs2-0040" title="PeritiP , MazzeiT , MiniE , NovelliA . Adverse effects of macrolide antibacterials. Drug Safety1993;9(5):346‐64. ">Periti 1993</a>). </p> </section> <section id="CD004783-sec-0084"> <h4 class="title">Natural history and microbiological findings</h4> <p>Natural history and microbiological findings also support the non‐use of antimicrobials. Almost 20 years ago bacterial pathogens such as <i>M. catarrhalis</i> and <i>H. influenzae</i> were implicated in the genesis of upper respiratory tract infection (URTI) and acute laryngitis. This conclusion was based on studies that confirmed that carriage of these pathogens is an uncommon feature in healthy adults (<a href="./references#CD004783-bbs2-0016" title="DiGiovanniC , RileyTV , HoyneGF , YeoR , CookseyP . Respiratory tract infections due to Branhamella catarrhalis: epidemiological data from Western Australia. Epidemiology and Infection1987;99:445‐53. ">DiGiovanni 1987</a>; <a href="./references#CD004783-bbs2-0017" title="EjlertsenT , ThistedE , EbbesenF , OlesenB , RennebergJ . Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. Journal of Infection1994;29:23‐31. ">Ejlertsen 1994</a>; <a href="./references#CD004783-bbs2-0045" title="SchalenL , ChristensenP , KammeC , MiornerH , PetterssonKI , SchalenC . High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scandinavian Journal of Infectious Diseases1980;12(4):277‐80. ">Schalen 1980</a>). The involvement of the larynx in a viral infection could, in a proportion of patients, lead to bacterial superinfection with extensions to the upper and lower respiratory tract. </p> <p>The high nasopharyngeal isolation rates of <i>M. catarrhalis</i> (50% in both studies) and <i>H. influenzae</i> (15% in the penicillin V trial and 20% in the erythromycin trial) were apparently consistent with the use of antibiotics for this condition. However, after one week the voice profiles appeared to be essentially normalised in both antibiotic and placebo groups in both trials; no relevant differences were found in clinical symptoms assessed by the participants apart from the above described. These findings support the conclusion that the disorder is generally self limiting, and the majority of participants in the studies may have been suffering from viral URTIs. </p> <p>Isolates of <i>M. catarrhalis</i>, as reported by Schalén et al in both trials (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>; <a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>), were obtained from swabs placed in haematin agar tubes and inoculated onto haematin agar plates in 6% CO<sup>2</sup> atmosphere as well as onto blood agar plates incubated anaerobically. <i>M. catarrhalis</i>, considered by the authors to be the principal bacterial pathogen related to acute laryngitis, was confirmed by fermentation reactions and by testing for species‐specific protein antigen. If no growth was found, the swabs kept in the haematin agar tubes were streaked and incubated as above. </p> <p>Over the years the following criteria have been used to clearly identify <i>M. catarrhalis</i> from other bacterial species: gram stain (<a href="./references#CD004783-bbs2-0054" title="VerduinCM , HolC , FleerA , vanDijkH , vanBelkumA . Moraxella catarrhalis: from emerging to established pathogen. Clinical Microbiology Reviews2002;15(1):125‐44. ">Verduin 2002</a>); colony morphology; lack of pigmentation of the colony on blood agar; oxidase production; DNAase production; failure to produce acid from glucose, sucrose, fructose, lactose and maltose; growth at 22°C on nutrient agar; failure to grow on modified Thayer‐Martin medium; and, finally, reduction of nitrite and nitrate. Currently, the identity of this pathogen is best confirmed by positive reactions in at least three of the following tests, since none are 100% sensitive or specific by themselves: positive reaction for DNAase production, reduction of nitrate and nitrite and tributyrin hydrolysis (<a href="./references#CD004783-bbs2-0012" title="CatlinBW . Branhamella catarrhalis: an organism gaining respect as a pathogen. Clinical Microbiology Reviews1990;3:293‐320. ">Catlin 1990</a>). Furthermore, polymerase chain reaction (PCR) tests are currently considered an unequalled diagnostic assay (<a href="./references#CD004783-bbs2-0022" title="GreinerO , DayPJ , AltweggM , NadalD . Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real‐time PCR. Journal of Clinical Microbiology2003;41(4):1386‐90. ">Greiner 2003</a>; <a href="./references#CD004783-bbs2-0041" title="PostJC , PrestonRA , AulJJ , Larkins‐PettigrewM , Rydquist‐WhiteJ , AndersonKW , et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA1995;273:1598‐604. ">Post 1995</a>; <a href="./references#CD004783-bbs2-0042" title="PostJC , WhiteJ , AulJJ , ZavoralT , WadowskyRM , ZhangY , et al. Development and validation of a multiplex PCR‐based assay for the upper respiratory tract bacterial pathogens Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. Molecular Diagnosis1996;1:29‐39. ">Post 1996</a>). Modern tests show that the methods used in the present trials to identify <i>M. catarrhalis</i> may have introduced some misclassification in the percentage of isolates of this pathogen in participants with acute laryngitis. </p> <p>By the years 1980 and 1990, the presence of B‐lactamase in isolates of <i>M. catarrhalis</i> from the United States was 75% and 80% respectively. By 1990, B‐lactamase was in over 90% of isolates from England and Scotland; and, by 2003, in 87.4% of isolates from China (<a href="./references#CD004783-bbs2-0019" title="FungCP , PowellM , SeymourA , YuanM , WilliamsJD . The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991. Journal of Antimicrobial Chemotherapy1992;30:47‐55. ">Fung 1991</a>; <a href="./references#CD004783-bbs2-0029" title="JorgensenJH , DoernGV , MaherLA , HowellAW , ReddingJS . Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy1990;34(11):2075‐80. ">Jorgensen 1990</a>; <a href="./references#CD004783-bbs2-0055" title="WallaceRJ , NashDR , SteingrubeVA . Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. American Journal of Medicine1990;88:46S‐50S. ">Wallace 1990</a>; <a href="./references#CD004783-bbs2-0056" title="WangH , YuYS , LiuY , LiHY , HuBJ , SunZY , et al. Resistance surveillance of common community respiratory pathogens isolated in China, 2002‐2003 (abstract). Zhonghua Jie He He Hu Xi Za Zhi2004;27(3):155‐60. ">Wang 2003</a>). In a study conducted in the United States, most isolates of <i>M. catarrhalis</i> were resistant to amoxicillin, cefaclor, cefprozil and trimethoprim/sulfamethoxazole; among <i>H. influenzae</i> isolates, 28.6% were B‐lactamase positive (<a href="./references#CD004783-bbs2-0028" title="JacobsMR , BajaksouzianS , WindauA , GoodCE , LinG , PankuchGA , et al. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998‐2001 US Surveillance Study. Clinics in Laboratory Medicine2004;24:503‐30. ">Jacobs 2004</a>). In the present penicillin trial, 18% of <i>M. catarrhalis</i> isolated at the acute visit produced B‐lactamase. </p> </section> </section> <section id="CD004783-sec-0085"> <h3 class="title" id="CD004783-sec-0085">Overall completeness and applicability of evidence</h3> <p>There were only three randomised controlled trials (RCTs) in this review and the data are incomplete for a number of clinically important outcomes. In addition there was no opportunity to pool data. The applicability of the evidence outside the research setting is reasonable as these studies were conducted in clinical settings that were quite similar. The comparisons in the review are commonly undertaken and not difficult to apply. Two RCTs were conducted in Sweden and another one in Russia. </p> </section> <section id="CD004783-sec-0086"> <h3 class="title" id="CD004783-sec-0086">Quality of the evidence</h3> <p>The quality of the evidence was very low for all outcomes, as per the GRADE approach. The main reasons for downgrading the quality of the evidence were limitations in study design or execution (risk of bias), imprecision and inconsistency of results. The review included three small trials, which we judged as having moderate to high risk of bias, mainly because allocation concealment methods were not adequately reported, no blinding was performed, outcomes measure were not adequately defined and concomitant treatments were unclear in some trials. Another limitation was incomplete outcome reporting (e.g. continuous outcomes failed to provide standard deviations in several RCTs) and no reporting of baseline characteristics. In two of the studies, diagnosis was made through indirect laryngoscopy (<a href="./references#CD004783-bbs2-0002" title="SchalénL , ChristensenP , EliassonI , FexS , KammeC , SchalenC . Inefficacy of penicillin V in acute laryngitis in adults. Evaluation from results of double‐blind study. Annals of Otology, Rhinology, and Laryngology1985;94(1 Pt 1):14‐7. ">Schalén 1985</a>; <a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a>). A more accurate diagnostic approach would have required a more specialised examination. These RCTs assessed different interventions resulting in very limited opportunities to pool useful data. Publication bias could not be evaluated, given the small number of trials identified for each comparison. </p> </section> <section id="CD004783-sec-0087"> <h3 class="title" id="CD004783-sec-0087">Potential biases in the review process</h3> <p>We have produced updated coverage of RCTs of antibiotics for laryngitis in adults by summarising the best available evidence using quantitative methods. We endeavoured to provide information to help clinicians and stakeholders choose the most appropriate treatment. We searched several sources to identify RCTs. However, we cannot be sure that all available RCTs were identified. We included a new trial published only as a conference abstract and the results of this study need to be verified by publication in a peer‐reviewed journal. Although acute laryngitis is often diagnosed using clinical criteria, laryngoscopic findings are needed for a clear diagnosis. The RCTs included in this review did not use more specialised examination of the larynx. </p> </section> <section id="CD004783-sec-0088"> <h3 class="title" id="CD004783-sec-0088">Agreements and disagreements with other studies or reviews</h3> <p>Acute laryngitis often involves rhino‐pharyngo‐laryngitis or rhinosinubronchitis with involvement of the larynx. A Cochrane Review assessing the effect of antibiotics in adults with clinically diagnosed rhinosinusitis in primary care settings found that although antibiotics can shorten the time to cure (number needed to treat to benefit (NNTB) 18 (95% CI 10 to 115), significantly more participants who received antibiotics experienced adverse events (number needed to treat to harm (NNTH) 8 (95% CI 6 to 13) (<a href="./references#CD004783-bbs2-0032" title="LemiengreMB , vanDrielML , MerensteinD , YoungJ , DeSutterAI . Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews2012, Issue 10. [DOI: 10.1002/14651858.CD006089.pub4] ">Lemiengre 2012</a>). The authors concluded that there is no place for antibiotics in patients with clinically diagnosed, uncomplicated acute rhinosinusitis. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004783-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD004783-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study" data-id="CD004783-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Fusafungine versus fusafungine + clarithromycin, Outcome 1 Clinical cure rates at day 5 ± 1." data-id="CD004783-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Fusafungine versus fusafungine + clarithromycin, Outcome 1 Clinical cure rates at day 5 ± 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Fusafungine versus fusafungine + clarithromycin, Outcome 2 Clinical cure rates at day 8 ± 1." data-id="CD004783-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Fusafungine versus fusafungine + clarithromycin, Outcome 2 Clinical cure rates at day 8 ± 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Fusafungine versus fusafungine + clarithromycin, Outcome 3 Clinical cure rates at day 28 ± 2." data-id="CD004783-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Fusafungine versus fusafungine + clarithromycin, Outcome 3 Clinical cure rates at day 28 ± 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Fusafungine versus fusafungine + clarithromycin, Outcome 4 Frequency of adverse events." data-id="CD004783-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Fusafungine versus fusafungine + clarithromycin, Outcome 4 Frequency of adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Fusafungine versus no treatment, Outcome 1 Clinical cure rates at day 5 ± 1." data-id="CD004783-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Fusafungine versus no treatment, Outcome 1 Clinical cure rates at day 5 ± 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Fusafungine versus no treatment, Outcome 2 Clinical cure rates at day 8 ± 1." data-id="CD004783-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Fusafungine versus no treatment, Outcome 2 Clinical cure rates at day 8 ± 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Fusafungine versus no treatment, Outcome 3 Clinical cure rates at day 28 ± 2." data-id="CD004783-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Fusafungine versus no treatment, Outcome 3 Clinical cure rates at day 28 ± 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fusafungine + clarithromycin versus no treatment, Outcome 1 Clinical cure rates at day 5 ± 1." data-id="CD004783-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Fusafungine + clarithromycin versus no treatment, Outcome 1 Clinical cure rates at day 5 ± 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fusafungine + clarithromycin versus no treatment, Outcome 2 Clinical cure rates at day 8 ± 1." data-id="CD004783-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Fusafungine + clarithromycin versus no treatment, Outcome 2 Clinical cure rates at day 8 ± 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Fusafungine + clarithromycin versus no treatment, Outcome 3 Clinical cure rates at day 28 ± 2." data-id="CD004783-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Fusafungine + clarithromycin versus no treatment, Outcome 3 Clinical cure rates at day 28 ± 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Erythromycin versus placebo, Outcome 1 Laryngitis at 1 week." data-id="CD004783-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Erythromycin versus placebo, Outcome 1 Laryngitis at 1 week.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Erythromycin versus placebo, Outcome 2 Laryngitis at 2 week." data-id="CD004783-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Erythromycin versus placebo, Outcome 2 Laryngitis at 2 week.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Erythromycin versus placebo, Outcome 3 Elimination rate of Moraxella catarrhalis at 1 week." data-id="CD004783-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Erythromycin versus placebo, Outcome 3 Elimination rate of Moraxella catarrhalis at 1 week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Erythromycin versus placebo, Outcome 4 Elimination rate of Moraxella catarrhalis at 2 week." data-id="CD004783-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Erythromycin versus placebo, Outcome 4 Elimination rate of Moraxella catarrhalis at 2 week. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Erythromycin versus placebo, Outcome 5 Patients having voice disturbance at week 1." data-id="CD004783-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Erythromycin versus placebo, Outcome 5 Patients having voice disturbance at week 1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Erythromycin versus placebo, Outcome 6 Patients having voice disturbance at week 2." data-id="CD004783-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Erythromycin versus placebo, Outcome 6 Patients having voice disturbance at week 2. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Erythromycin versus placebo, Outcome 7 Cough at week 1 (subjective symptom)." data-id="CD004783-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Erythromycin versus placebo, Outcome 7 Cough at week 1 (subjective symptom).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004783-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/urn:x-wiley:14651858:media:CD004783:CD004783-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_t/tCD004783-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Erythromycin versus placebo, Outcome 8 Cough at week 2 (subjective symptom)." data-id="CD004783-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Erythromycin versus placebo, Outcome 8 Cough at week 2 (subjective symptom).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/media/CDSR/CD004783/image_n/nCD004783-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004783-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Fusafungine compared with no treatment for acute laryngitis in adults</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with acute laryngitis </p> <p><b>Settings:</b> ambulatory </p> <p><b>Intervention:</b> fusafungine </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> No treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Fusafungine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical cure rates at day 8 ± 1</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.07 (0.88 to 1.31)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>93 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Comparing a 7‐day course of fusafungine (6 times a day by inhalations) versus no treatment (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>778 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>832 per 1000</b> <br/> (684 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>One study with design limitations. Wide confidence interval crossing the line of no effect and small sample size. Serious imprecision and very serious risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004783-tbl-0002"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Fusafungine plus clarithromycin compared with no treatment for acute laryngitis in adults</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with acute laryngitis </p> <p><b>Settings:</b> ambulatory </p> <p><b>Intervention:</b> fusafungine plus clarithromycin </p> <p><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Fusafungine plus clarithromycin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Clinical cure rates at day 8 ± 1</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.09 (0.90 to 1.32)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>97 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Comparing a 7‐day course of fusafungine (6 times a day by inhalations) plus clarithromycin (250 mg twice a day for 7 days) versus no treatment (<a href="./references#CD004783-bbs2-0001" title="RafalskiyVV , GurevitchAS , OtvaginIV , DovganEVA . Randomized comparative study of 7‐days courses of fuzafungine vs. fuzafungine and clarithromycin in patients with acute laryngitis. 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) of the American Society for Microbiology. Available at: http://www.icaaconline.com/php/icaac2013abstracts/data/papers/2012/L1/2012_L1‐299.htm (accessed February 3, 2015), 2012; Vol. 52:L1299. ">Rafalskiy 2012</a>) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>778 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>848 per 1000</b> <br/> (700 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>One study with design limitations. Wide confidence interval crossing the line of no effect and small sample size. Serious imprecision and very serious risk of bias </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004783-tbl-0003"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin compared with placebo for acute laryngitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> adults with acute laryngitis </p> <p><b>Settings:</b> ambulatory </p> <p><b>Intervention:</b> erythromycin </p> <p><b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Erythromycin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Laryngitis at 1 week</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.10 (0.76 to 1.59)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Erythromycin 500 mg twice a day for 5 days <a href="./references#CD004783-bbs2-0003" title="SchalénL , EliassonI , KammeC , SchalenC . Erythromycin in acute laryngitis in adults. Annals of Otology, Rhinology, and Laryngology1993;102(3 Pt 1):209‐14. ">Schalén 1993</a> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>510 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>561 per 1000</b> <br/> (387 to 811) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Laryngitis at 2 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81 (0.44 to 1.49)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>270 per 1000</b> <br/> (147 to 497) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Patients having voice disturbance at 1 week</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.87 (0.59 to1.28)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>549 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>478 per 1000</b> <br/> (324 to 703) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Patients having voice disturbance at 2 weeks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.56 (0.28 to 1.14)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>99 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>187 per 1000</b> <br/> (93 to 380) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>One study with design limitations. Wide confidence interval crossing the line of no effect and small sample size. Serious imprecision and risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/full#CD004783-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004783-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Fusafungine versus fusafungine + clarithromycin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical cure rates at day 5 ± 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.77, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical cure rates at day 8 ± 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.83, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical cure rates at day 28 ± 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.80, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Frequency of adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.19, 3.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Fusafungine versus fusafungine + clarithromycin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004783-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Fusafungine versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical cure rates at day 5 ± 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [1.02, 2.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical cure rates at day 8 ± 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.88, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical cure rates at day 28 ± 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.82, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Fusafungine versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004783-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Fusafungine + clarithromycin versus no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical cure rates at day 5 ± 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [1.00, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical cure rates at day 8 ± 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.90, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Clinical cure rates at day 28 ± 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.78, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Fusafungine + clarithromycin versus no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004783-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Erythromycin versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Laryngitis at 1 week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.76, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Laryngitis at 2 week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.44, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Elimination rate of Moraxella catarrhalis at 1 week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.64 [1.34, 5.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Elimination rate of Moraxella catarrhalis at 2 week <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.36, 1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Patients having voice disturbance at week 1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.46, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Patients having voice disturbance at week 2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.28, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Cough at week 1 (subjective symptom) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.49, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Cough at week 2 (subjective symptom) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.15, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Erythromycin versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004783.pub5/references#CD004783-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004783.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004783-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004783-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004783-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004783-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD004783-note-0004">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD004783-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD004783-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004783\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004783\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004783\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004783\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004783\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004783.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004783.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004783.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004783.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004783.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714454245"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004783.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714454249"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004783.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6f155e8a9377',t:'MTc0MDcxNDQ1NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 